{"entity":{"type":"insider","cik":"0001730056","url":"/insider/0001730056","json_url":"/insider/0001730056.json","name":"Sprague John M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2020-03-03","last":"2023-03-09","span_basis":"filed_date"},"name_variants":[{"name":"Sprague John M","source":"filing","n_filings":4,"first_seen":"2020-03-03","last_seen":"2023-03-09"}],"transactions":[{"id":7939120,"accession":"0000899243-23-007726","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-007726","line_url":"/filing/0000899243-23-007726#line-4","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001730056","owner_name":"Sprague John M","owner_display_name":"Sprague John M","owner_url":"/insider/0001730056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1148.0,"shares_display":"1,148","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":677.32,"total_display":"677.32","total_whole":"677","shares_owned_after":7268.0,"shares_owned_after_display":"7,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-09","scope":"insider"},{"id":7939117,"accession":"0000899243-23-007726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-007726","line_url":"/filing/0000899243-23-007726#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001730056","owner_name":"Sprague John M","owner_display_name":"Sprague John M","owner_url":"/insider/0001730056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1545.0,"shares_display":"1,545","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":1004.25,"total_display":"1,004.25","total_whole":"1,004","shares_owned_after":5502.0,"shares_owned_after_display":"5,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-03-09","scope":"insider"},{"id":6532456,"accession":"0000899243-22-014414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014414","line_url":"/filing/0000899243-22-014414#line-1","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001730056","owner_name":"Sprague John M","owner_display_name":"Sprague John M","owner_url":"/insider/0001730056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4767,"price_display":"0.48","price_state":"stated","total_value":4767.0,"total_display":"4,767.00","total_whole":"4,767","shares_owned_after":152350.0,"shares_owned_after_display":"152,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-11","scope":"insider"},{"id":4811577,"accession":"0000899243-21-007774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-007774","line_url":"/filing/0000899243-21-007774#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001730056","owner_name":"Sprague John M","owner_display_name":"Sprague John M","owner_url":"/insider/0001730056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5250.0,"shares_display":"5,250","price_per_share":2.04,"price_display":"2.04","price_state":"stated","total_value":10710.0,"total_display":"10,710.00","total_whole":"10,710","shares_owned_after":35485.0,"shares_owned_after_display":"35,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-23","scope":"insider"},{"id":2777790,"accession":"0000899243-20-006668","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-006668","line_url":"/filing/0000899243-20-006668#line-2","is_derivative":false,"issuer_cik":"0001492674","issuer_name":"T2 Biosystems, Inc.","issuer_ticker":"TTOO","issuer_name_source":null,"issuer_url":"/issuer/0001492674","owner_cik":"0001730056","owner_name":"Sprague John M","owner_display_name":"Sprague John M","owner_url":"/insider/0001730056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":3416.12,"total_display":"3,416.12","total_whole":"3,416","shares_owned_after":22222.0,"shares_owned_after_display":"22,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492674","name":"T2 Biosystems, Inc.","url":"/issuer/0001492674","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2020-03-03","last_seen":"2023-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001730056","retrieved_at":"2026-08-25T19:46:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}